Other microRNAs, such as miR-885-3p, have been shown to target the AKT pathway beneficially, for instance, improving glucocorticoid sensitivity in Graves’ ophthalmopathy by inhibiting AKT/NFKB signaling47. The gene discussed is NFKB1; the disease is Graves ophthalmopathy.